Resveratrol and the Controversy Surrounding its Use as an Enzyme Activator

This chapter explores the research conducted by biologist David Sinclair on the activation of cert genes using resveratrol and its potential benefits. It discusses the clinical trials conducted by Sinclair's company, Sertris Pharmaceuticals, and the controversy surrounding the safety of resveratrol. The chapter also questions the validity of Sinclair's claims and highlights alternative approaches like niacinamide.